Nissen‑Sleeve versus Roux‑en‑Y gastric bypass for reflux in people with severe obesity
Official title: The SLEEVE-GERD Trial: A Comparative Study of Nissen-Sleeve and Roux-en-Y Gastric Bypass in Obese Patients With GERD
Run by Jagiellonian University · NCT07158008 · Data updated 2026-11-12
This trial tests whether Nissen‑Sleeve gastrectomy or Roux‑en‑Y gastric bypass better controls GERD symptoms in adults who are eligible for bariatric surgery due to severe obesity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 560 (estimated) |
| Sponsor | Jagiellonian University Academic / other |
| Locations | 1 site (Krakow) |
| Status | Recruiting |
| Started | July 31, 2025 |
| Main results expected | July 31, 2028 |
| Study ends | September 2028 |
| Registry record updated | September 5, 2025 |
| Trial ID | NCT07158008 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) eligible for bariatric surgery (BMI ≥40 or ≥35 with comorbidities) who have symptomatic GERD defined by regular PPI use, a GerdQ >6, or endoscopic esophagitis, and who have not had prior upper GI or anti‑reflux surgery and are non‑smokers.
✕Probably not a fit
Patients without GERD, those with prior upper gastrointestinal or anti‑reflux surgery, active smokers, or those not eligible for bariatric surgery are unlikely to benefit from enrollment in the randomized comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial will directly compare Nissen‑Sleeve gastrectomy (a sleeve gastrectomy combined with a 360° fundoplication wrap) to Roux‑en‑Y gastric bypass (RYGB) in adults with obesity and symptomatic GERD, with an observational sleeve gastrectomy group for patients without GERD. Participants meeting bariatric criteria and GERD definitions will be randomized to N‑SG or RYGB and followed for safety, reflux control, nutritional outcomes, and need for further procedures. The trial highlights differences in anatomical alteration, endoscopic access to the biliary tree, and potential long‑term nutritional risks between the two approaches. Outcomes will inform whether the newer N‑SG technique can match RYGB’s reflux control while preserving gastrointestinal continuity.
Why it matters
Potential benefit: If successful, the Nissen‑Sleeve approach could offer similar reflux control to RYGB while preserving normal GI continuity and reducing long‑term nutritional issues and limitations on endoscopic access.
How similar studies have gone: Roux‑en‑Y gastric bypass is an established, effective anti‑reflux bariatric operation, while Nissen‑Sleeve is a newer hybrid technique with encouraging early observational reports but limited randomized data to date.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For N-Sleeve Gastrectomy (N-SG) and Roux-en-Y Gastric Bypass (RYGB) arms: * Age ≥ 18 years * Written informed consent provided * Eligible for bariatric surgery according to national guidelines (BMI ≥ 40 kg/m² or BMI ≥ 35 kg/m² with obesity-related comorbidities) * Presence of symptomatic gastroesophageal reflux disease (GERD), defined by at least one of the following: * Regular use of proton pump inhibitors (PPIs) * GerdQ score \> 6 * Endoscopic evidence of esophagitis (Los Angeles classification grade B or higher) For Sleeve Gastrectomy (SG) observational control group: * Age ≥ 18 years * Written informed consent provided * Eligible for bariatric surgery according to national guidelines (BMI ≥ 40 kg/m² or BMI ≥ 35 kg/m² with obesity-related comorbidities) * No symptoms or history of GERD Exclusion Criteria: * History of prior anti-reflux surgery * History of upper gastrointestinal tract surgery * Active smoking or history of nicotine use * Severe cardiac insufficiency (New York Heart Association Class III or IV) * Pregnancy or planned pregnancy during the study period (if applicable based on future additions) * Any condition that, in the opinion of the investigator, would interfere with the participant's ability to comply with the study protocol or would pose additional risk
Where it's running
-
Szpital Uniwersytecki w Krakowie
Krakow, Poland Recruiting
Study contacts
- Study coordinator: Piotr Małczak, PhD, MD
- Email: piotr.malczak@uj.edu.pl
- Phone: 0048124002600
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Endoscopic conversion of sleeve gastrectomy to a new bypass method for reflux and obesity
This study is testing a new, less invasive procedure to help people who haven't lost enough weight or have gained weight back after sleeve gastrectomy by converting it to a different type of bypass surgery.
-
Impact of Sleeve Gastrectomy on Bone and Muscle Health in Men and Women
This study is trying to see how sleeve gastrectomy affects bone and muscle health in men and women over three years.
-
15-year outcomes after sleeve gastrectomy in France
This study looks at how people who had sleeve gastrectomy have fared over 15 years to see long-term weight changes and health effects.
-
Mother and baby health after bariatric surgery in pregnancy
This study follows pregnant women who have had bariatric surgery and those who have not to see how nutrition, pregnancy health, and baby outcomes compare.
-
Understanding glucagon and sugar metabolism after meals in people with and without PBH after weight-loss surgery
This study tests how glucagon and post-meal glucose handling differ between people who have post-bariatric surgery hypoglycemia and those who don’t.
-
Collagen Supplements After Sleeve Gastrectomy
This observational study looks to see if taking collagen-containing supplements after sleeve gastrectomy affects muscle mass, body composition, and body image in adults who had bariatric surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.